Clinical Trials Browser

Phase 2 × Pathologic Complete Response × TP protocol × Clear all

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response